Landscapes / Companies

iCell Gene Therapeutics not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
Phase 2
Next date
ICG318, Phase 1/2 trial completes
Drugs
3
in active trials · 7 in all
Trials
6 active
12 since 2021

Drugs3

DrugHow it worksPartnerStageNext dateDetails
—
Phase 2 7 Apr 2028Phase 1/2 trial completes
—
Phase 1 4 Jul 2028Phase 1 trial completes
—
Phase 1 —

About

No active trial
anti-CD33 CAR T cells, anti-CD5 CAR T cells, CD4 CAR T cells, CD7 CAR T cells
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow ICell Gene Therapeutics

Following is part of Solo: you see every change to ICell Gene Therapeutics the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in